The system earned FDA clearance in October and made its debut in April. The system is designed for SI joint fusion when treating sacroiliac joint disruptions, degenerative sacroiliitis and other conditions. It has a Transfixing-Cone, an ilium screw, a sacrum screw and associated instruments.
“The release of SiLO TFX is proceeding smoothly and rapidly as we deploy more instruments sets and implants into the field,” Petra Lopizzo, Aurora Spine’s director of operations, said in the release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
